Lilly’s Zyprexa, Cymbalta Will Be Dropped From Florida Medicaid Drug List
Executive Summary
Florida Medicaid will reconsider the status of GlaxoSmithKline's Paxil, Forest's Lexapro and Pfizer's Zoloft on the state's preferred drug list in September after awarding the antidepressants conditional placement on the PDL
You may also be interested in...
Pfizer Lipitor, Detrol Removed From Florida Medicaid Preferred Drug List
Florida Medicaid recipients will have to try at least two other drugs in the same category before they are allowed to receive any of six Pfizer drugs recently removed from the state's preferred drug list
Pfizer Lipitor, Detrol Removed From Florida Medicaid Preferred Drug List
Florida Medicaid recipients will have to try at least two other drugs in the same category before they are allowed to receive any of six Pfizer drugs recently removed from the state's preferred drug list
Florida Medicaid
Florida Medicaid's preferred drug list will include Pfizer's Zoloft, Forest's Lexapro and GlaxoSmithKline's Paxil CR, Wellbutrin XL and Lamictal after the manufacturers renegotiated prices for the mental health products. The drugs were not initially recommended for inclusion by the Florida pharmacy & therapeutics committee under revisions to the Medicaid PDL (1"The Pink Sheet" July 11, 2005, p. 11). Wyeth's Effexor XR and Lilly's antidepressants (Cymbalta, Prozac Weekly, Sarafem) and antipsychotics (Zyprexa and Symbyax) are among the products that will require prior authorization...